The Current Ratio as of November 2024 (TTM) for Sosei Group Corporation (SOLTF) is 4.11

According to Sosei Group Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 4.11. This represents a change of 6.72% compared to the average of 3.85 of the last 4 quarters.

Sosei Group Corporation (SOLTF) Historical Current Ratio (quarterly & annually)

How has SOLTF Current Ratio performed in the past?

The mean historical Current Ratio of Sosei Group Corporation over the last ten years is 10.04. The current 4.11 Current Ratio has changed 3.99% with respect to the historical average. Over the past ten years (40 quarters), SOLTF's Current Ratio was at its highest in in the September 2022 quarter at 20.73. The Current Ratio was at its lowest in in the December 2018 quarter at 0.

Sosei Group Corporation (SOLTF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Sosei Group Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sosei Group Corporation (SOLTF) Average Current Ratio

How has SOLTF Current Ratio performed in the past?

The current Current Ratio of Sosei Group Corporation (SOLTF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sosei Group Corporation (SOLTF) Current Ratio vs. Peers

How is SOLTF’s Current Ratio compared to its peers?

Sosei Group Corporation’s Current Ratio is greater than Gain Therapeutics, Inc. (2.99), greater than BioVie Inc. (2.95), greater than IN8bio, Inc. (1.84), less than NewAmsterdam Pharma Company N.V. (10.61), greater than Cue Biopharma, Inc. (2.22), less than uniQure N.V. (6.51), less than Rocket Pharmaceuticals, Inc. (6.05), greater than Rhythm Pharmaceuticals, Inc. (3.49), less than Solid Biosciences Inc. (7.85), greater than MeiraGTx Holdings plc (2.34), less than Apellis Pharmaceuticals, Inc. (4.36), greater than Blueprint Medicines Corporation (3.32), less than Karuna Therapeutics, Inc. (19.31), less than Mirati Therapeutics, Inc. (7.54), less than Day One Biopharmaceuticals, Inc. (14.62), less than VectivBio Holding AG (9.14), less than AVROBIO, Inc. (26.17), less than Zura Bio Limited (10.36), less than Elevation Oncology, Inc. (17.77), greater than Hepion Pharmaceuticals, Inc. (1.30),

Build a custom stock screener for Sosei Group Corporation (SOLTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sosei Group Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sosei Group Corporation (SOLTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sosei Group Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.